Welcome to the New Era of Enhanced Immune Systems
We’re changing how the world sees the immune system
Building on Nobel Prize-winning immune network theory, we’re transforming cutting-edge immunological research into real-world therapies for both companion animals and humans. By viewing the immune system as a dynamic network—not just isolated parts—we’re developing smarter, more effective treatments that enhance and rebalance immune function at its core.
Our technology is revolutionizing immunology.
The problem we’re solving
Our technology doesn’t just manage symptoms—it addresses the root causes of immune dysfunction. By restoring balance deep within the immune system, we’re creating lasting solutions for allergy and autoimmune diseases in both dogs and humans.
Who we are
Currently, 13 team members, we bring expertise in corporate development, scientific research, veterinary medicine, and investment relations.
Together, we bring 247 years of experience and 22 commercialized products brought to market
Product Pipeline
First dogs, then humans
Our preclinical data highlight the strength of our platform technology. In multiple animal models, we’ve shown lasting reductions in allergic responses, colitis, and inflammatory autoimmune diseases. These results are supported by five peer-reviewed publications, demonstrating broad therapeutic potential.
NI-CAN-001: Enhancing the lives of dogs with allergies
Projected date: 2025*
Mode of application: Injectable (under the skin)
Our therapy helps dogs with allergies feel better by resetting their immune system. Instead of just covering up the symptoms, it teaches the body to stop overreacting to things like pollen, dust, or food. That means less itching, fewer flare-ups, and a happier, more comfortable life for your dog.
NI-CAN-002: Supporting happier, healthier lives for dogs with autoimmune disorders
When a dog has an autoimmune disorder, their immune system turns against their own body. Our therapy changes that. It helps reset the immune system so it stops attacking healthy cells and starts working the way it should. The result? Fewer symptoms, less medication, and a better life for dogs living with these chronic conditions.
Projected date: 2026*
Mode of application: Injectable (under the skin)
NI-CAN-003: Improving digestive health and wellbeing in dogs with colitis
Projected date: 2027*
Mode of application: Injectable (under the skin)
Colitis can cause painful, chronic digestive issues for dogs. Our therapy targets the root cause—an out-of-balance immune response in the gut. By calming and resetting the immune system, we help reduce inflammation, improve digestion, and bring relief that lasts—so dogs can get back to enjoying life.
Looking towards the future
NI-HUM-001: A first-of-its-kind therapy designed to rebalance the immune system—reducing allergy symptoms by addressing their root cause, not just masking them.
Projected date: 2028*
Mode of application: Injectable (under the skin)
NI-HUM-002: Designed for autoimmune conditions, this breakthrough therapy retrains the immune system to stop attacking the body—offering a smarter, more stable path to long-term relief.
Mode of application: Injectable (under the skin)
Projected date: 2028*